Navigation
banner

Rhonda Rhyne

Chief Executive Officer

Prevencio

 
Rhonda Rhyne

Rhonda Rhyne has more than 25 years of executive medical technology research and commercialization experience and is currently CEO, Chief Translational Medicine Officer and Board Director for Prevencio, Inc., a Seattle-based company developing multi-protein blood tests for obstructive heart disease; 1-year risk for myocardial infarct, stroke, and CV death; obstructive peripheral artery disease…and more. She also serves as Board Director for Aminex Therapeutics and OtoNexus Medical Technologies, both Seattle-area companies. As a medical technology industry leader, Rhonda has received multiple awards, including Ernst & Young’s Entrepreneur of the Year–Medical Products, San Diego; Deloitte’s Fast 50 for 50 Fastest Growing Technology and Life Science Companies in Southern California; San Diego’s Business Journal’s Women Who Mean Business; and Athena’s Pinnacle Individual in BioSciences. Rhonda also authored the women’s leadership book, Keys to the Corner Office: Success Strategies for Women by Women (www.keytothecorneroffice.com). A portion of net proceeds is donated to OUR Rescue, a nonprofit dedicated to fighting sex trafficking. Rhonda received her Bachelor of Pharmacy from Washington State University and MBA from University of California, Los Angeles (UCLA). @rhondarhyne, www.linkedin.com/in/rhondarhyne, www.prevenciomed.com

Follow Rhonda Rhyne' at upcoming/ongoing conferences at gtcbio:

Cardiovascular Biomarkers